Table: Xebio Holdings - 9-MTH group results
Feb 7 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2019 Dec 31, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 173.95 174.30 238.42
(-0.2 pct) (-1.3 pct) (+2.9 pct)
Operating 4.58 6.56 6.93
(-30.2 pct) (-36.7 pct) (+20.2 pct)
Recurring 5.02 7.11 7.60
(-29.5 pct) (-34.3 pct) (+13.0 pct)
Net 1.66 3.66 2.10
(-54.7 pct) (-35.2 pct) (+11.6 pct)
EPS 37.45 yen 82.17 yen 47.57 yen
EPS Diluted 37.35 yen 81.99 yen
Ann Div 35.00 yen 35.00 yen
-Q2 div 17.50 yen 17.50 yen
-Q4 div 17.50 yen 17.50 yen
NOTE - Xebio Holdings Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T